[1] Petta S,Torres D,Fazio G,et al. Carotid atherosclerosis and chronic hepatitis C:a prospective study of risk associations. Hepatology,2012,55（5）:1317-1323.
[2] Zampino R,Marrone A,Restivo L,et al. Chronic HCV infection and inflammation:Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol,2013,5（10）:528-540.
[3] 中华医学会肝病学分会和传染病与寄生虫病学分会.丙型肝炎防治指南. 中华肝脏病杂志,2004,12（4）:194-198.
[4] Ebrahim S,Papacosta O,Whincup P,et al. Carotid plaque,intimametia thickness,cardiovescular risk factors,and prevalent cardiovescular diseases in men and women:the British Regional Heart Study. Stroke,1999,30（4）:841-850.
[5] Mencin A,Kluwe J,Schwabe RF. Toll-like receptors as tagets in chronic liver diseases. Gut,2009,58（5）:704-720.
[6] Sandler NG,Koh C,Roque A,et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology,2011,141（4）:1220-1230.
[7] Dahl TB,Yndestad A,Skjelland M,et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis:possible role in inflammation and plaque destabilization. Circulation,2007,115（8）:972-980.
[8] Zhong M,Tan HW,Gong HP,et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol （ Oxf）,2008,69（6）:878-884.
[9] Zampino R,Marrone A,Restivo L,et al. Chronic HCV infection and inflammation:Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol,2013,5（10）:528-540.
[10] Alyan O,Kacmaz F,Ozdemir O,et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J,2008,72（12）:1960-1965.
[11] Aksakal E,Tanboga IH,Kurt M,et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis,2012,221（2）:596-601.
[12] Shabbir S,Khan FA. Serum gamma glutamyltransferase:a novel biomarker for screening of premature coronary artery disease. Cardiovasc Revasc Med ,2011,12（6）:367-374.
[13] Du G,Song Z,Zhang Q. Gammaglutamyl transferase is associated with cardiovascular and all-cause mortality:a meta-analysis of prospective cohort studies. Prev Med,2013,57(1):31-37.
[14] Franzini M,Corti A,Martinelli B,et al. Cammaglutamyl transferase activity in human atherosclerotic plaques biochemical similarities with the circulating enzyme. Atherosclerosis,2009,202（1）:119-127.
[15] Boddi M,Abbate R,Chellini B,et al. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol,2010,47(1): 72-75.
[16] Matsumori A,Shimada T,Chapman NM,et al. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail,2006,12（4）:293-298.
[17] Boddi M,Abbate R,Chellini B,et al. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Dig Liver Dis, 2007,39(1):S55-S60.
[18] Luigi E,Adinolfi E,Luciano R,et al. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV related steatosis. Atherosclerosis,2012,221（2）:496-502. |
